OR WAIT null SECS
Marks the fifth shot to receive emergency approval by Indian health authorities
India has authorized Johnson & Johnson's single-dose Covid-19 vaccine for emergency use, Mansukh Mandaviya, the country’s minister of health and family welfare said in a tweet last weekend, as reported by Reuters. J&J noted that it was still too early to give a timeline in terms of when those doses would be delivered, but the company said that the vaccine would be brought to India through a supply agreement with local vaccine manufacturer Biological E Ltd, according to Reuters.
This marks the fifth shot approved for emergency use by Indian health authorities thus far, with AstraZeneca, Bharat Biotech, Russia’s Gamaleya Research Institute and Moderna being the others.
Despite the emergency approval of Moderna's vaccine in June, not a single dose has been received by India yet, as a result of a dispute concerning legal protection that was requested by the vaccine maker.
The latest numbers provided by The New York Times demonstrate that India has administered over 519 million Covid vaccine doses, with 30% of the adult population being at least partially vaccinated, receiving at least one dose of a vaccine.